Gun Ei Chemical Industry (4229) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
22 Jul, 2026Executive summary
Net sales for the nine months ended December 31, 2024, were ¥22,702 million, down 2.2% year-over-year.
Operating profit declined 29.5% year-over-year to ¥1,694 million.
Profit attributable to owners of parent decreased 24.3% to ¥1,394 million.
Comprehensive income dropped 52.6% year-over-year to ¥1,561 million.
Financial highlights
Gross profit for the nine months was ¥4,842 million, down from ¥5,474 million year-over-year.
Operating income fell to ¥1,694 million from ¥2,405 million year-over-year.
Ordinary income decreased to ¥1,978 million from ¥2,686 million year-over-year.
Basic earnings per share for the period was ¥210.33, compared to ¥278.08 the previous year.
Total assets as of December 31, 2024, were ¥61,755 million, with net assets at ¥51,062 million.
Outlook and guidance
Full-year net sales forecast is ¥30,600 million, up 1.0% year-over-year.
Operating profit is projected at ¥2,200 million, down 19.4% year-over-year.
Profit attributable to owners of parent is forecast at ¥1,700 million, down 16.7% year-over-year.
Basic earnings per share for the full year is expected to be ¥256.37.
Annual dividend forecast remains unchanged at ¥100 per share.
Latest events from Gun Ei Chemical Industry
- Profit surged in H1 as pricing and environmental materials offset weak electronics demand.4229
Q2 2024 - Profit rebounded sharply, but FY25 guidance anticipates margin pressure amid major capacity investment.4229
Q4 2024 - Sales and operating profit rose sharply, but net profit fell on extraordinary losses.4229
Q1 2027 - Quarterly sales and profits declined year-over-year, with lower full-year profit guidance.4229
Q1 2025 - H1 earnings fell, but semiconductor strength lifted profit guidance as the sales outlook was cut.4229
Q2 2025 - Sales rose, operating profit fell, and FY2031 targets include ¥40 billion operating profit.4229
Q4 2025 - Sales rose slightly, but profits declined; full-year outlook expects lower earnings.4229
Q1 2026 - H1 sales and operating profit rose, while net profit edged lower and FY guidance held.4229
Q2 2026 - FY26 earnings and comprehensive income rose; FY27 guidance remains uncertain.4229
Q4 2026